CellSource Co., Ltd.
4880.T · JPX
10/31/2025 | 10/31/2024 | 10/31/2023 | 10/31/2022 | |
|---|---|---|---|---|
| Revenue | ¥3,711 | ¥4,355 | ¥4,511 | ¥4,274 |
| % Growth | -14.8% | -3.4% | 5.5% | – |
| Cost of Goods Sold | ¥1,624 | ¥1,938 | ¥1,326 | ¥1,210 |
| Gross Profit | ¥2,087 | ¥2,417 | ¥3,185 | ¥3,064 |
| % Margin | 56.2% | 55.5% | 70.6% | 71.7% |
| R&D Expenses | ¥0 | ¥71 | ¥72 | ¥88 |
| G&A Expenses | ¥0 | ¥291 | ¥302 | ¥324 |
| SG&A Expenses | ¥1,921 | ¥396 | ¥406 | ¥425 |
| Sales & Mktg Exp. | ¥0 | ¥105 | ¥104 | ¥101 |
| Other Operating Expenses | ¥0 | ¥1,821 | ¥1,485 | ¥980 |
| Operating Expenses | ¥1,921 | ¥2,288 | ¥1,963 | ¥1,493 |
| Operating Income | ¥167 | ¥129 | ¥1,221 | ¥1,571 |
| % Margin | 4.5% | 3% | 27.1% | 36.8% |
| Other Income/Exp. Net | -¥57 | ¥166 | ¥18 | ¥13 |
| Pre-Tax Income | ¥110 | ¥295 | ¥1,240 | ¥1,584 |
| Tax Expense | ¥99 | ¥57 | ¥317 | ¥566 |
| Net Income | ¥11 | ¥238 | ¥923 | ¥1,018 |
| % Margin | 0.3% | 5.5% | 20.5% | 23.8% |
| EPS | 0.54 | 12.01 | 48.88 | 54.54 |
| % Growth | -95.5% | -75.4% | -10.4% | – |
| EPS Diluted | 0.54 | 11.96 | 47.93 | 52.98 |
| Weighted Avg Shares Out | 20 | 20 | 19 | 19 |
| Weighted Avg Shares Out Dil | 20 | 20 | 19 | 19 |
| Supplemental Information | – | – | – | – |
| Interest Income | ¥0 | ¥0 | ¥0 | ¥0 |
| Interest Expense | ¥1 | ¥1 | ¥0 | ¥0 |
| Depreciation & Amortization | ¥204 | ¥153 | ¥66 | ¥61 |
| EBITDA | ¥315 | ¥450 | ¥1,306 | ¥1,645 |
| % Margin | 8.5% | 10.3% | 29% | 38.5% |